These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 29378704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.
    Clin Ther; 2016 Jan 01; 38(1):16-30. PubMed ID: 26585355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.
    Hos NJ, Jazmati N, Stefanik D, Hellmich M, AlSael H, Kern WV, Rieg S, Wisplinghoff H, Seifert H, Kaasch AJ.
    J Infect; 2017 Mar 01; 74(3):248-259. PubMed ID: 28017826
    [Abstract] [Full Text] [Related]

  • 7. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Ishino K, Niki Y.
    Int J Antimicrob Agents; 2015 Nov 01; 46(5):532-7. PubMed ID: 26364848
    [Abstract] [Full Text] [Related]

  • 8. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chen WJ, Chang SC, Hsueh PR.
    Clin Infect Dis; 2012 Nov 15; 55(10):1329-37. PubMed ID: 22911641
    [Abstract] [Full Text] [Related]

  • 9. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM, Goff DA, Brown J, Khadem TM, Bauer KA.
    Clin Ther; 2013 Jun 15; 35(6):772-9. PubMed ID: 23795575
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR.
    J Antimicrob Chemother; 2014 Jan 15; 69(1):211-8. PubMed ID: 23997017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Britt NS, Patel N, Horvat RT, Steed ME.
    Antimicrob Agents Chemother; 2016 May 15; 60(5):3070-5. PubMed ID: 26953202
    [Abstract] [Full Text] [Related]

  • 15. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J, Yamaki J, Lou M, Hshieh S, Chu T, Shriner KA, Wong-Beringer A.
    Clin Ther; 2013 Jul 15; 35(7):995-1004. PubMed ID: 23829982
    [Abstract] [Full Text] [Related]

  • 16. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD.
    Int J Antimicrob Agents; 2015 Dec 15; 46(6):689-95. PubMed ID: 26555059
    [Abstract] [Full Text] [Related]

  • 17. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R, So H, Seo E, Kim M, Lee J.
    PLoS One; 2021 Dec 15; 16(4):e0247714. PubMed ID: 33793589
    [Abstract] [Full Text] [Related]

  • 18. Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.
    Yoon YK, Park DW, Sohn JW, Kim HY, Kim YS, Lee CS, Lee MS, Ryu SY, Jang HC, Choi YJ, Kang CI, Choi HJ, Lee SS, Kim SW, Kim SI, Kim ES, Kim JY, Yang KS, Peck KR, Kim MJ.
    Antimicrob Agents Chemother; 2014 Dec 15; 58(1):317-24. PubMed ID: 24165181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S.
    Antimicrob Agents Chemother; 2016 Sep 15; 60(9):5276-84. PubMed ID: 27324762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.